Delivery Order SPE2DB22D3301-SPE2DB24FX8FM

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,377.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets and has a completion date of December 10, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orilissa 150 mg tablets. The contract has a ceiling value of $6,430.25 and a completion date of October 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,059.98 firm-fixed-price contract is for the delivery of Orilissa 150 mg tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a $3,251.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Orilissa 150 mg tablets, a specialty medication. The order has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,383.04, is for the delivery of the drug Orilissa 150 mg tablet. It is a firm fixed-price delivery order contract with a completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,651.12 firm fixed-price delivery order is for the drug Orilissa 150 mg tablet, with a completion date of May 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,330.46 firm fixed-price contract is for the delivery of the specialty medication Orilissa 150 mg tablets. The contract is a child award under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Orilissa 150 mg tablets. The contract, valued at $8,753.96, is a firm fixed-price delivery order with an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Orilissa (Elagolix) 150 mg tablets. The contract has a ceiling value of $3,418.68 and a completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order (SPE2DB22D2007|SPE2DB24FJ0FZ) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,361.44, is for the delivery of the drug Orilissa 150 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. The IDC...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX8FM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,188.22, is for the supply of Orilissa 150 mg tablets to support federal healthcare programs.

The contract is a firm fixed-price delivery order with a performance period ending on January 8, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 5/13/25, 10:19 AM